Literature DB >> 27292878

Assessing the risk of marijuana use disorder among adolescents and adults who use marijuana.

Linda Richter1, Brandie S Pugh1, Samuel A Ball1,2.   

Abstract

BACKGROUND: The changing political and social climate surrounding marijuana use, coupled with the fact that available estimates of marijuana use disorder prevalence are outdated and do not adequately represent adolescents, underscore the need for up-to-date and comprehensive prevalence estimates of marijuana use disorder.
OBJECTIVES: To provide recent national estimates of marijuana use disorder as a function of usage patterns, age, and other sociodemographic, substance use, and mental health variables.
METHODS: Analyses of data from the 2014 National Survey on Drug Use and Health examined the prevalence of marijuana use disorder among respondents (N = 55,271) with various sociodemographic, substance use, and mental health characteristics. Logistic and multinomial regression analyses examined the correlates of marijuana use disorder as a function of these variables, with a special focus on age.
RESULTS: In 2014, 3.49% of lifetime, 11.62% of past-year, and 15.32% of past-30-day marijuana users met DSM-IV criteria for a marijuana use disorder; rates among youth generally were at least double those of adults across reported time frame and intensity of use. Regression analyses indicated that young age, black race/ethnicity, greater intensity of use, current tobacco/nicotine use, and alcohol and other drug use disorders were associated with increased odds of a marijuana use disorder.
CONCLUSIONS: A significant proportion of marijuana users, especially youth, are at risk for having a marijuana use disorder, even at relatively low levels of use.

Entities:  

Keywords:  Adolescents; cannabis; marijuana; marijuana use disorders; risk factors

Mesh:

Year:  2016        PMID: 27292878     DOI: 10.3109/00952990.2016.1164711

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  10 in total

1.  Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life.

Authors:  Yih-Ing Hser; Larissa J Mooney; David Huang; Yuhui Zhu; Rachel L Tomko; Erin McClure; Chih-Ping Chou; Kevin M Gray
Journal:  J Subst Abuse Treat       Date:  2017-07-29

2.  Greater risk for frequent marijuana use and problems among young adult marijuana users with a medical marijuana card.

Authors:  Joan S Tucker; Anthony Rodriguez; Eric R Pedersen; Rachana Seelam; Regina A Shih; Elizabeth J D'Amico
Journal:  Drug Alcohol Depend       Date:  2018-11-06       Impact factor: 4.492

3.  Racial and Ethnic Differences in Cannabis Use and Cannabis Use Disorder: Implications for Researchers.

Authors:  LaTrice Montgomery; Shapree Dixon; Dale S Mantey
Journal:  Curr Addict Rep       Date:  2022-01-05

Review 4.  Associations between cannabis use, cannabis use disorder, and mood disorders: longitudinal, genetic, and neurocognitive evidence.

Authors:  Lauren Kuhns; Emese Kroon; Karis Colyer-Patel; Janna Cousijn
Journal:  Psychopharmacology (Berl)       Date:  2021-11-06       Impact factor: 4.415

5.  Biological correlates of self-reported new and continued abstinence in cannabis cessation treatment clinical trials.

Authors:  Nathaniel L Baker; Kevin M Gray; Brian J Sherman; Kristen Morella; Gregory L Sahlem; Amanda M Wagner; Aimee L McRae-Clark
Journal:  Drug Alcohol Depend       Date:  2018-04-16       Impact factor: 4.492

6.  Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder.

Authors:  Rachel L Tomko; Nathaniel L Baker; Caitlyn O Hood; Amanda K Gilmore; Erin A McClure; Lindsay M Squeglia; Aimee L McRae-Clark; Susan C Sonne; Kevin M Gray
Journal:  Psychopharmacology (Berl)       Date:  2019-11-11       Impact factor: 4.530

7.  Cyber-ethnography of cannabis marketing on social media.

Authors:  Marina C Jenkins; Lauren Kelly; Kole Binger; Megan A Moreno
Journal:  Subst Abuse Treat Prev Policy       Date:  2021-04-26

8.  Cannabinoids-Perspectives for Individual Treatment in Selected Patients: Analysis of the Case Series.

Authors:  Michał Graczyk; Agata Anna Lewandowska; Piotr Melnyczok; Adam Zgliński; Małgorzata Łukowicz
Journal:  Biomedicines       Date:  2022-08-02

Review 9.  Pro-Inflammatory Cytokines: Potential Links between the Endocannabinoid System and the Kynurenine Pathway in Depression.

Authors:  Ferenc Zádor; Sâmia Joca; Gábor Nagy-Grócz; Szabolcs Dvorácskó; Edina Szűcs; Csaba Tömböly; Sándor Benyhe; László Vécsei
Journal:  Int J Mol Sci       Date:  2021-05-31       Impact factor: 5.923

10.  Why Young Adults Obtain a Medical Marijuana Card: Associations with Health Symptoms and Heaviness of Use.

Authors:  Justin F Hummer; Rachana Seelam; Eric R Pedersen; Joan S Tucker; David J Klein; Elizabeth J D'Amico
Journal:  Cannabis       Date:  2021-04-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.